Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling

BACKGROUND: Histone deacetylase (HDAC) inhibitors are promising anti-fibrosis drugs; however, nonselective inhibition of class I and class II HDACs does not allow a detailed elucidation of the individual HDAC functions in renal fibrosis. In this study, we investigated the effect of MS-275, a selecti...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Liu, Na, He, Song, Ma, Li, Ponnusamy, Murugavel, Tang, Jinhua, Tolbert, Evelyn, Bayliss, George, Zhao, Ting C., Yan, Haidong, Zhuang, Shougang
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2013
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3546966/
https://ncbi.nlm.nih.gov/pubmed/23342059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0054001
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים